Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-expressed protein 22 (TEX22) is a protein coded by the TEX22 gene, highly and specifically expressed in the testis, with predicted location in the acrosomal vesicle of developing sperm cells[4]. TEX22 is thought to play a role in early spermatogenesis, first expressed in prepubertal testis, possibly involved in male fertility, and associated with spermatogenic failure if dysfunctional[2][4]. However, its molecular mechanism, cellular pathways, and clinical significance as a therapeutic target remain undetermined. No evidence links TEX22 to drug interaction, nor does current research classify it within well-known protein families such as receptors, enzymes, ion channels, or transcription factors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-expressed protein 22 (TEX22).